Pfizer Creates COO Role for CEO Ian Read's Rumored Successor
Albert Bourla, 56, has been the Group President of Pfizer’s Innovative Health Business since the beginning of 2016. Source: BioSpace
Albert Bourla, 56, has been the Group President of Pfizer’s Innovative Health Business since the beginning of 2016. Source: BioSpace
Denali plans to make a $100M IPO under the symbol DNLI. Source: BioSpace
Alex Azar was head of U.S. operations for Lilly until January. Source: BioSpace
During the presidential campaign of 2015-2016, one of the areas that got some of the largest scrutiny was drug pricing, and with good reason. Source: BioSpace
There's nothing like a billion-plus dollar deal to make investors happy on a Monday. Source: BioSpace
Noting that biotech stocks have been in "hypergrowth" mode over more than six years, George Budwell, writing for The Motley Fool, looks at three biotech stocks that he would recommend…
Pfizer is planning to hire 200 new staffers and another 200 replacement workers in Michigan. Source: BioSpace
The investment is not part of Gates’ philanthropic Bill & Melinda Gates Foundation and will be followed with another $50 million in a number of start-up ventures working in Alzheimer’s…
After falling short of analysts' expectations in its latest quarter, Novo Nordisk is restructuring its commercial operations as it looks to fend off challenges to its products. Source: BioSpace
The initial results were presented at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting. Source: BioSpace